Hip regeneration Surprise: care choices without a promise to regrow the joint

The place that hurts gives the clinician a useful start

A deep groin ache often points to wear in the hip joint. You may feel it when the leg turns or carries weight. An ache over the bony side can start in nearby tendons. That area often hurts when you lie on the sore side. Your back can make the same area sore as well.

An old injury may leave the joint easy to stir up. Years of use can bring slow changes too. Wear may appear on an X-ray, yet the image can't name the cause alone. The exam must match the image with your painful movement.

Fever plus heat and swelling around the hip needs prompt medical care. Sudden severe soreness after a joint procedure also needs quick attention.

Gentle movement can help until the hip is examined

For mild soreness, pause the motion that brought it on. Keep your hip moving easily, but don't force a sharp catch. A cane or walker can reduce strain during a difficult spell. Physical therapy may help with strength and safer movement.

An exam is worth arranging when soreness cuts into your sleep, walking, or dressing. If an older X-ray is available, take it with you. Tell the clinician the exact spot that hurts and which motion starts it. Also say how long the ache has been there.

At its Peoria clinic, QC Kinetix offers platelet-rich plasma (PRP), a regenerative treatment made by drawing a patient's blood, spinning it to separate the layers, and giving the platelet-rich part as a shot.

That care is non-surgical, but it isn't proof that the joint will rebuild. The visit can cover cost, likely follow-up, and the next choice when relief doesn't last.

Sources

1. A Bayesian network meta-analysis of 11 randomized trials (1353 patients) in hip osteoarthritis found that at 2-4 months and 6 months NO injectable - corticosteroid, hyaluronic acid or platelet-rich plasma - significantly outperformed a saline placebo injection for pain or function. Pooled change from baseline exceeded the minimal clinically important difference in every arm including placebo.

   Gazendam A, et al. — Intra-articular saline injection is as effective as corticosteroids, platelet-rich plasma and hyaluronic acid for hip osteoarthritis pain: a systematic review and network meta-analysis of randomised controlled trials.. British Journal of Sports Medicine, 2021. DOI: 10.1136/bjsports-2020-102179.

2. The RESTORE trial - a participant-, injector- and assessor-blinded RCT of 288 adults aged 50+ with symptomatic medial knee OA (Kellgren-Lawrence 2-3) - compared three weekly intra-articular PRP injections against saline placebo, with co-primary endpoints of 12-month knee pain and medial tibial cartilage volume on MRI. PRP did not beat placebo on either. It is the single best-designed test of the specific claim that PRP changes joint structure, and it was negative.

   Bennell KL, et al. — Effect of Intra-articular Platelet-Rich Plasma vs Placebo Injection on Pain and Medial Tibial Cartilage Volume in Patients With Knee Osteoarthritis: The RESTORE Randomized Clinical Trial.. JAMA, 2021. DOI: 10.1001/jama.2021.19415.

3. A four-arm, multicentre, single-blind phase 2/3 randomized trial of 480 knee OA patients (KL II-IV) compared autologous bone marrow aspirate concentrate, autologous adipose stromal vascular fraction and allogeneic umbilical-cord-tissue mesenchymal stromal cells against a corticosteroid injection control. At 12 months NONE of the three orthobiologic injections was superior to another, or to the corticosteroid control, and none of the four groups showed a significant change in MRI osteoarthritis score from baseline. No procedure-related serious adverse events occurred.

   Mautner K, et al. — Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial.. Nature medicine, 2023. DOI: 10.1038/s41591-023-02632-w.

4. The strongest recent POSITIVE signal: a meta-analysis of 10 RCTs (818 patients, KL I-III) found intra-articular MSC injection beat hyaluronic acid at 12 months on WOMAC total (MD -10.22), VAS (MD -1.31) and on the MRI Whole-Organ Magnetic Resonance Imaging Score (MD -26.01), all reaching the minimal clinically important difference, with no significant difference in adverse events. Recorded here at full weight: this result and the negative RESTORE and Mautner trials are both in the literature, and an honest page reports both.

   Jin WS, et al. — Mesenchymal Stem Cells Injection Is More Effective Than Hyaluronic Acid Injection in the Treatment of Knee Osteoarthritis With Similar Safety: A Systematic Review and Meta-analysis.. Arthroscopy : the journal of arthroscopic & related surgery : official publication of the Arthroscopy Association of North America and the International Arthroscopy Association, 2025. DOI: 10.1016/j.arthro.2024.07.027.

5. A network meta-analysis restricted to LARGE intra-articular trials (57 RCTs, 22,795 participants, >=100 patients per group) found treatment effects were consistently larger in the 35 high-risk-of-bias trials than in the 22 low/unclear-risk trials. Excluding high-risk trials, triamcinolone had the highest probability of exceeding the minimal important difference at weeks 2 and 6; hyaluronic acid had no effect on pain (SMD -0.04, 95% CI -0.19 to 0.11) with higher odds of dropouts due to adverse events (OR 2.01) and serious adverse events (OR 1.86) than placebo. Effects of 16 of 18 interventions were smaller than the MID.

   Pereira TV, et al. — Effectiveness and safety of intra-articular interventions for knee and hip osteoarthritis based on large randomized trials: A systematic review and network meta-analysis.. Osteoarthritis and Cartilage, 2025. DOI: 10.1016/j.joca.2024.08.014.